We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PAS market cap is 572.1k. The company's latest EPS is CAD -0.0105 and P/E is -0.95.
Year End 30 November 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 6k | 672k |
Operating Income | -2.84M | -983k | -786k | -291k | -622k |
Net Income | -3.41M | -1.24M | -1.09M | -480k | -400k |
Year End 30 November 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 455k | 121k | 155k | 18k | 2.5M |
Total Liabilities | 111k | 473k | 646k | 962k | 1.12M |
Total Equity | 344k | -352k | -491k | -944k | 1.38M |
Year End 30 November 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -3.27M | -862k | -615k | -148k | -385k |
Investing | -2k | N/A | N/A | 9k | -948k |
Financing | N/A | 471k | 623k | 155k | 1.76M |
Market Cap | 572.1k |
Price to Earnings Ratio | -0.95 |
Price to Sales Ratio | 0.57 |
Price to Cash Ratio | 0.91 |
Price to Book Ratio | 0.28 |
Dividend Yield | - |
Shares Outstanding | 38.14M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0 (0%) |
Company Name | Pascal Biosciences Inc |
Address |
1900 airport way s, suite 201 seattle, washington 98134 |
Website | https://www.nevisbrands.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions